Patent details
EP3952868 Title: COMBINATIONS OF NITAZOXANIDE OR TIZOXANIDE AND ELAFIBRANOR FOR THE TREATMENT OF PRIMARY BILIARY CHOLANGITIS- OR PRIMARY SCLEROSING CHOLANGITIS-ASSOCIATED INFLAMMATION
Basic Information
- Publication number:
- EP3952868
- PCT Application Number:
- EP2020059941
- Type:
- European Patent Granted for LU
- Legal Status:
- Unitary Effect Registered
- Application number:
- EP207154212
- PCT Publication Number:
- WO2020208044
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- COMBINATIONS OF NITAZOXANIDE OR TIZOXANIDE AND ELAFIBRANOR FOR THE TREATMENT OF PRIMARY BILIARY CHOLANGITIS- OR PRIMARY SCLEROSING CHOLANGITIS-ASSOCIATED INFLAMMATION
- French Title of Invention:
- COMBINAISONS DU NITAZOXANIDE OU DU TIZOXANIDE ET DE L'ELAFIBRANOR DESTINÉE AU TRAITEMENT DES INFLAMMATIONS ASSOCIÉES À LA CHOLANGITE SCLÉROSANTE PRIMITIVE OU À LA CHOLANGITE BILIAIRE PRIMITIVE
- German Title of Invention:
- KOMBINIERUNGEN AUS NITAZOXANID ODER TIZOXANID UND ELAFIBRANOR ZUR BEHANDLUNG VON PRIMÄR BILIÄRE CHOLANGITIS- ODER PRIMÄR SKLEROSIERENDE CHOLANGITIS-ASSOZIIERTEN ENTZÜNDUNGEN
- SPC Number:
Unitary Effect
- Unitary Effect Requested:
- Yes
- Unitary Effect Request Filing Date:
- 08/09/2025
- Link to UPP Register:
- European Patent Register
- Unitary Effect Request Withdrawal Date:
- Unitary Effect Status:
- Unitary Effect Registered
- Unitary Effect Acceptance Decision Date:
- 15/09/2025
- Unitary Effect Rejection Decision Date:
- Unitary Effect Date:
- 13/08/2025
- Unitary Effect Registration Date:
- 15/09/2025
- Unitary Effect Re-establishment of rights Filing Date:
- Unitary Effect Re-establishment of rights EPO Decision :
- Unitary Effect Re-establishment of rights EPO Decision Date:
- Explanatory Text UE:
- Safety Net Request Date:
- Safety Net Decision Date:
- Safety Net Decision Outcome:
- SPC Number:
Dates
- Filing date:
- 07/04/2020
- Grant date:
- 13/08/2025
- EP Publication Date:
- 16/02/2022
- PCT Publication Date:
- 15/10/2020
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 13/08/2025
- EP B1 Publication Date:
- 13/08/2025
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 07/04/2040
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 06/08/2025
- Name:
- Genfit
- Address:
- 885 avenue Eugène Avinée, 59120 Loos, France (FR)
Inventor
1
- Name:
- PARROCHE, Peggy
- Address:
- France (FR)
2
- Name:
- WALCZAK, Robert
- Address:
- France (FR)
Priority
- Priority Number:
- 19305463
- Priority Date:
- 09/04/2019
- Priority Country:
- European Patent Office (EPO) (EP)
Classification
- IPC classification:
- A61K 31/426; A61K 31/192; A61K 45/06; A61P 1/16; A61P 29/00; A61P 37/00; A61P 43/00; A61K 9/00;
Publication
European Patent Bulletin
1
- Issue number:
- 202533
- Publication date:
- 13/08/2025
- Description:
- Grant (B1)
2
- Issue number:
- 202542
- Publication date:
- 15/10/2025
- Description:
- Unitary Effect Request Receipt
3
- Issue number:
- 202542
- Publication date:
- 15/10/2025
- Description:
- Unitary Effect Request Acceptance
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|